Join Bullfrog AI’s Exclusive Live Investor Webinar and Q&A Session on April 23

Core Insights - Bullfrog AI Holdings, Inc. is hosting a webinar on April 23, 2025, to discuss its innovative use of AI and machine learning in drug development [1] - The company's proprietary bfLEAP™ platform, developed at Johns Hopkins Applied Physics Lab, aims to uncover hidden biological insights and optimize clinical strategies [2] - Bullfrog AI is pursuing a dual growth strategy by generating recurring revenue through its Data Networks platform while advancing a pipeline of licensed drug assets in collaboration with leading research institutions [2] Company Overview - Bullfrog AI leverages AI and machine learning to enhance drug discovery and development, aiming to streamline therapeutics development and reduce clinical trial failure rates [4] - The company utilizes causal AI in combination with its bfLEAP™ platform to analyze complex biological data [4] Webinar Details - The webinar will include a live question and answer session following the presentation, allowing attendees to engage directly with the company's CEO [3] - Registration for the free webinar is available online, and questions can be pre-submitted or asked during the event [3]